可持续性
MAKING AN IMPACT
At Repligen, sustainability is a strategic priority that impacts all aspects of our organization. Through a balanced approach that blends stakeholder engagement, employee empowerment and strategic investments, we have committed to driving positive impacts across environmental, social and governance topics that are material to our business.
ADVANCING IMPACTS
Formally embracing sustainability into our company culture and embedding its principles into daily operations influences how we work and enables us to effect positive change in multiple areas. We are pleased to share our “Advancing Impacts” sustainability report for 2023, which demonstrates how we are moving sustainability forward and making meaningful, measurable impacts.
Repligen Corporation’s six key impact areas
PRODUCTS & PACKAGING
OPERATIONS
TALENT
SUPPLY CHAIN
COMMUNITIES
PARTNERSHIPS & PATHWAYS
Our six key impact areas are a newly adopted and streamlined organizational format created to optimize how we communicate our sustainability advancements and ambitions through annual reporting.
2023 IMPACT HIGHLIGHTS
Maintained an MSCI AA “Leader” rating* within the Health Care Equipment and Supplies constituent group and Low Risk by Morningstar Sustainalytics** with recognition as an ESG Industry “Top Rated” company.
Received four silver and one bronze site-level EcoVadis scores based on customer evaluations of Repligen sustainability practices as a supplier.
Submitted our first CDP Climate Survey and received an Awareness rating on par with Global, North American and Medical equipment and supplies sector average ratings.
Powered 13 of 18 manufacturing sites with 100% renewable electricity (up from 9 of 18), representing 88% of our total global consumption (up from 82%) and 72% of total emissions (up from 62%).
Rolled out progressive talent development and pipeline programs to address feedback from our 2023 employee engagement survey, which had 90% participation and a 76% favorability rating.
Increased the percentage of women in management, defined as Associate Director and above, from 27% to 29% and the percent of our global employee base represented by women employees from 34% to 35%.
Focused on DEI education and recruiting efforts contributing to a near 50/50 balance of U.S. employees self-reporting as either white or people of color in 2023.
Awarded €600,000 training grant by Ireland’s Investment Development Authority to implement a comprehensive strategic talent development plan over the next three years.
Achieved a 60% increase in productivity savings through the Repligen Performance System (RPS) compared to 2022.
Improved our risk management and sustainability management capabilities for the future; selected a more robust software platform, being implemented in 2024.
Committed to net-zero emissions by 2050 with the Science Based Targets initiative (SBTi).
Join the Repligen team
Working at Repligen means being part of a team that is excited to find new and creative ways to overcome challenges in bioprocessing — and to help our customers make a difference in the world.
